BSE Live
Nov 28, 16:00Prev. Close
2531.90
Open Price
2530.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 28, 15:58Prev. Close
2530.70
Open Price
2530.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2560.80 (84)
| Balance Sheet of Ajanta Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 17.54 | 17.54 | 17.69 | 17.69 | 17.69 | |
| Total Share Capital | 17.54 | 17.54 | 17.69 | 17.69 | 17.69 | |
| Reserves and Surplus | 2,443.29 | 2,123.44 | 1,913.81 | 1,486.25 | 1,107.10 | |
| Total Reserves and Surplus | 2,443.29 | 2,123.44 | 1,913.81 | 1,486.25 | 1,107.10 | |
| Total Shareholders Funds | 2,461.30 | 2,142.08 | 1,931.50 | 1,503.94 | 1,124.79 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 13.82 | |
| Deferred Tax Liabilities [Net] | 81.16 | 58.90 | 47.00 | 27.38 | 20.11 | |
| Other Long Term Liabilities | 16.10 | 0.33 | 0.00 | 1.83 | 0.46 | |
| Long Term Provisions | 15.65 | 13.44 | 13.16 | 3.15 | 2.59 | |
| Total Non-Current Liabilities | 112.91 | 72.67 | 60.16 | 32.36 | 36.98 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 46.05 | |
| Trade Payables | 302.77 | 185.53 | 211.47 | 145.31 | 145.04 | |
| Other Current Liabilities | 163.01 | 102.90 | 71.73 | 54.13 | 50.68 | |
| Short Term Provisions | 9.16 | 18.33 | 16.99 | 12.80 | 11.36 | |
| Total Current Liabilities | 474.94 | 306.76 | 300.19 | 212.24 | 253.13 | |
| Total Capital And Liabilities | 3,049.15 | 2,521.51 | 2,291.85 | 1,748.54 | 1,414.90 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 1,429.36 | 1,155.38 | 1,029.29 | 566.97 | 429.08 | |
| Intangible Assets | 10.57 | 6.65 | 7.40 | 5.96 | 3.75 | |
| Capital Work-In-Progress | 131.06 | 261.29 | 61.33 | 338.03 | 238.42 | |
| Other Assets | 9.39 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 1,580.38 | 1,423.32 | 1,098.02 | 912.19 | 672.63 | |
| Non-Current Investments | 18.63 | 18.26 | 18.26 | 17.26 | 17.25 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 6.28 | 0.00 | 0.00 | 0.00 | 21.11 | |
| Other Non-Current Assets | 28.78 | 30.05 | 80.56 | 44.02 | 4.27 | |
| Total Non-Current Assets | 1,634.07 | 1,471.63 | 1,196.84 | 973.47 | 715.26 | |
| CURRENT ASSETS | ||||||
| Current Investments | 67.14 | 64.74 | 182.38 | 181.56 | 66.39 | |
| Inventories | 436.19 | 414.26 | 317.37 | 179.28 | 189.78 | |
| Trade Receivables | 734.24 | 423.38 | 464.42 | 336.00 | 350.48 | |
| Cash And Cash Equivalents | 87.85 | 35.87 | 38.67 | 22.84 | 33.02 | |
| Short Term Loans And Advances | 6.28 | 0.00 | 0.00 | 0.00 | 59.24 | |
| OtherCurrentAssets | 83.38 | 111.63 | 92.17 | 55.39 | 0.73 | |
| Total Current Assets | 1,415.08 | 1,049.88 | 1,095.01 | 775.07 | 699.64 | |
| Total Assets | 3,049.15 | 2,521.51 | 2,291.85 | 1,748.54 | 1,414.90 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 182.41 | 306.30 | 173.65 | 146.19 | 123.97 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 29.77 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 72.17 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 164.22 | 210.19 | 161.55 | 220.58 | 64.06 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | 0.63 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | 952.71 | |
| Other Earnings | 1,442.05 | 1,068.17 | 1,166.73 | 1,147.70 | 89.47 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 18.63 | 18.26 | 18.26 | 17.26 | 24.20 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 15.34 | 36.97 | -- | -- | 76.78 | |
| Current Investments Unquoted Book Value | 51.80 | 27.77 | 182.38 | 181.56 | -- |
11.11.2025
10.11.2025
Ajanta Pharma Standalone September 2025 Net Sales at Rs 1,220.24 crore, up 8.09% Y-o-Y
04.11.2025
04.11.2025
Ajanta Pharma Consolidated September 2025 Net Sales at Rs 1,353.73 crore, up 14.08% Y-o-Y
10.11.2025
Ajanta Pharma Standalone September 2025 Net Sales at Rs 1,220.24 crore, up 8.09% Y-o-Y
04.11.2025
Ajanta Pharma Consolidated September 2025 Net Sales at Rs 1,353.73 crore, up 14.08% Y-o-Y
29.07.2025
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
29.07.2025
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
12.07.2023
Ajanta Pharma Q1 PAT seen up 9.1% YoY to Rs 190.5 cr: Nirmal Bang
13.07.2022
Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct
11.01.2019
Ajanta Pharma Q3 PAT may dip 35.1% YoY to Rs. 95.8 cr: ICICI Direct
12.10.2018
Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct